Dendritic cells and the promise of therapeutic vaccines for human immunodeficiency virus (HIV)-1.

Keyphrases

• Human Immunodeficiency Virus Type 1 (HIV-1) 100%
• Dendritic Cells 100%
• Therapeutic Vaccine 100%
• Human Immunodeficiency virus-1 Infection 66%
• CD4+ T 33%
• Adaptive Immune Response 33%
• Patients with Cancer 16%
• Clinical Setting 16%
• Healthy Individuals 16%
• Immune Response 16%
• Antiviral Drugs 16%
• CD8+ 16%
• Healthy Volunteers 16%
• CD8+ T Cells 16%
• Clinical Benefit 16%
• Cell Response 16%
• Infected Patients 16%
• Cellular Immunity 16%
• Naïve T Cells 16%
• Innovative Approach 16%
• Innate Immune Response 16%
• Current Therapies 16%
• Professional Antigen-presenting Cells 16%
• Vaccine Adjuvant 16%

Immunology and Microbiology

• Human Immunodeficiency Virus 1 100%
• Dendritic Cell 100%
• Normal Human 33%
• Cytotoxic T-Cell 33%
• Adaptive Immune System 33%
• Immunotherapy 16%
• Adoptive Immunity 16%
• CD4 16%
• T-Helper Cell 16%
• Infectious Agent 16%
• Immune Response 16%
• Antigen-Presenting Cell 16%
• Naive T Cell 16%
• Innate Immune System 16%
• Adjuvant 16%